-

DoseMe Enables Precision Dosing at Independence Health System

Up to 30 Percent Time Savings for Patient Consults with Vital Accuracy and Efficiency Now Achieved in Dosing

JUPITER, Fla.--(BUSINESS WIRE)--DoseMe, a leading provider of model-informed precision dosing (MIPD) software, has announced its collaboration with Excela Health, now part of Independence Health System. This alliance will advance therapeutic drug monitoring and optimize pharmacogenetics integration into pharmacokinetic/pharmacodynamic (PK/PD) models as part of IHS’s precision dosing strategy and initiatives.

“DoseMe’s user friendly software is our preferred method of dosing as it takes away guess work and laborious time searching for updated records, freeing up our pharmacists to focus on what they do best,” said Robert Letterio, Pharmacy Supervisor at Independence. “The predictability is amazing and time savings for clinicians is anywhere from 25 – 30% per patient. We will continue to integrate new capabilities including AUC protocols with the incredible support of the DoseMe staff and extensive resource library.”

Independence Health System offers patients nationally recognized quality care in cardiology, orthopedics, palliative care, and maternity as well as a broad range of surgical, medical, emergency, and behavioral health services, and an extensive network of primary care physicians. With five hospitals, nearly 1,000 healthcare providers and more than 7,000 employees, Independence Health System serves a ten county region and is the largest employer in Butler and Westmoreland counties.

Dr. Sharmeen Roy, PharmD, BCPS, Chief Strategy and Science Officer, remarks on the partnership: “IHS’s commitment to excellence aligns perfectly with DoseMe’s vision. Our joint effort in precision dosing is set to decrease adverse drug events and cut healthcare costs significantly – key objectives in our shared agenda to enhance patient outcomes.”

Looking forward, DoseMe’s innovative solutions will be fundamental for modern medicine, offering unprecedented accuracy in medication management. For more information on precision dosing models offered by DoseMe, visit https://doseme-rx.com/why-dosemerx/drug-packages

About DoseMe

DoseMe combines smart technology with science, leveraging clinically validated PK/PD models, patient characteristics, drug concentrations, and genotype to accurately individualize a dose in seconds. The platform is HIPAA, ISO & FDA compliant and the only Bayesian dosing platform to be HITRUST CSF certified. For more information on successful applications of its products, DoseMeRx and DoseMe Analytics, visit https://doseme-rx.com/success-stories

Contacts

Alison Guzzio
aguzzio@dosemehealth.com
484-459-3243

DoseMe


Release Versions

Contacts

Alison Guzzio
aguzzio@dosemehealth.com
484-459-3243

More News From DoseMe

DoseMe Acquires Firstline to Build End-to-End Clinical Decision Support for Health Systems in the Global Fight Against Infectious Disease

JUPITER, Fla. & VANCOUVER, British Columbia--(BUSINESS WIRE)--DoseMe, a global leader in model-informed precision dosing (MIPD) software and a portfolio company of Fairlong Capital, today announced the acquisition of Firstline, a leading clinical decision support platform utilized worldwide. Firstline enables clinicians to rapidly access local, evidence-based infectious disease treatment guidance, susceptibility patterns, and antimicrobial stewardship (AMS) resources. The combination of DoseMe...

Senior Care Partners (PACE) Advances Elderly Patient Safety with DoseMeRx

JUPITER, Fla.--(BUSINESS WIRE)--DoseMe, a leader in model-informed precision dosing (MIPD), today announced that Senior Care Partners (PACE) has implemented DoseMeRx to modernize vancomycin dosing in alignment with Area Under the Curve (AUC) guidelines. This advancement ensures standardized, efficient dosing practices across its team of three pharmacists, who manage a patient population of 600 outpatients. The decision to adopt DoseMeRx followed a thorough evaluation by multiple departments, in...

University Medical Centre Ljubljana and University Hospital of Maribor Elevate Antimicrobial Stewardship with DoseMeRx

JUPITER, Fla.--(BUSINESS WIRE)--DoseMe, a leader in model-informed precision dosing (MIPD), announced the University Medical Centre Ljubljana and University Hospital of Maribor have implemented DoseMeRx, an innovative therapeutic drug monitoring (TDM) platform. This marks a significant advancement in antimicrobial stewardship in Slovenia. Led by Clinical Pharmacist Tomi Laptoš at Ljubljana and Maja Petre at Maribor Hospital, both initiatives reflect a commitment to modernizing clinical pharmacy...
Back to Newsroom